Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bristol-Myers Squibb Company (BMY)

60.13   -0.63 (-1.04%) 10-24 22:55
Open: 60.83 Pre. Close: 60.76
High: 61.22 Low: 60.0717
Volume: 6,435,152 Market Cap: 135,529M
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in New York City, New York and currently employs 23,300 full-time employees. The firm's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The firm's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. The company offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. The Company’s subsidiary is Celgene Corp.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 61.393 - 61.733 61.733 - 62.01
Low: 59.011 - 59.496 59.496 - 59.89
Close: 59.42 - 60.136 60.136 - 60.717

Technical analysis

as of: 2020-10-23 4:41:20 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 72.91     One year: 85.15
Support: Support1: 59.01    Support2: 56.90
Resistance: Resistance1: 62.42    Resistance2: 72.91
Pivot: 60.58
Moving Average: MA(5): 60.47     MA(20): 60.36
MA(100): 59.84     MA(250): 60.24
MACD: MACD(12,26): 0.16     Signal(9): 0.19
Stochastic oscillator: %K(14,3): 56.06     %D(3): 58.44
RSI: RSI(14): 48.73
52-week: High: 68.34  Low: 45.76  Change(%): 8.2
Average Vol(K): 3-Month: 998611  10-Days: 903262

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BMY has closed above bottom band by 38.9%. Bollinger Bands are 13.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 24 Oct 2020
Hot Stock on Radar: Bristol-Myers Squibb Company (BMY) - Armenian Reporter

Fri, 23 Oct 2020
Gear up for the change! Bristol-Myers Squibb Company (BMY) has hit the volume of 1924602 - The InvestChronicle

Thu, 22 Oct 2020
Bristol Myers Squibb Stock Looks Attractive At $60 - Forbes

Wed, 21 Oct 2020
Bristol-Myers Squibb: Stock Price Trapped In A $50-$65 Range - Don't Expect That To Change Soon - Seeking Alpha

Mon, 19 Oct 2020
Were Hedge Funds Right About Bristol Myers Squibb Company (BMY)? - Yahoo Finance

Sat, 17 Oct 2020
Why I Think Bristol Myers Squibb Is Too Cheap to Miss - The Motley Fool

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 2,250
Shares Float (M) 2,250
% Held by Insiders 0.11
% Held by Institutions 79.09
Shares Short (K) 14,360
Shares Short P. Month (K) 14,450

Stock Financials

EPS -0.280
EPS Est This Year 3.000
EPS Est Next Year 3.230
Book Value (p.s.) 21.780
Profit Margin -1.61
Operating Margin 21.69
Return on Assets (ttm) 5.2
Return on Equity (ttm) -1.6
Qtrly Rev. Growth 61.5
Gross Profit (p.s.) 8.413
Sales Per Share 15.493
EBITDA (p.s.) 6.222
Qtrly Earnings Growth
Operating Cash Flow (M) 12,760
Levered Free Cash Flow (M) 15,790

Stock Valuations

PE Ratio -214.75
PEG Ratio 0.81
Price to Book value 2.76
Price to Sales 3.88
Price to Cash Flow 10.60

Stock Dividends

Dividend 1.760
Forward Dividend 1.800
Dividend Yield 0.03
Dividend Pay Date 2020-11-01
Ex-Dividend Date 2020-09-30
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.